FOXO TECHNOLOGIES INC. Research and Development Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Research and Development Expense of $23.70 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. research and development expense for the quarter ending 2026-06-30 was $23.70K, a 41.02% decline year-over-year.
- FOXO TECHNOLOGIES INC. research and development expense for the quarter ending 2026-03-31 was $35.55K, a 18.50% increase year-over-year.
- FOXO TECHNOLOGIES INC. research and development expense for the quarter ending 2025-12-31 was $35.22K.
- FOXO TECHNOLOGIES INC. research and development expense for the quarter ending 2025-09-30 was $77.10K, a 75.99% increase year-over-year.
- FOXO TECHNOLOGIES INC. research and development expense for fiscal 2025 was $182.50K, a 41.56% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. research and development expense for fiscal 2024 was $312.27K, a 65.32% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. research and development expense for fiscal 2023 was $900.43K, a 70.45% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. research and development expense for fiscal 2022 was $3.05M, a 37.55% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $23.70K 10-Q · filed 2026-08-14 | $59.25K 10-Q · filed 2026-08-14 | $94.47K derived: sum of 3 quarters · filed 2026-08-14 | $171.56K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $35.55K 10-Q · filed 2026-05-15 | $70.77K derived: sum of 2 quarters · filed 2026-05-15 | $147.87K derived: sum of 3 quarters · filed 2026-05-15 | $188.05K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $35.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $112.31K derived: sum of 2 quarters · filed 2026-04-15 | $152.50K derived: sum of 3 quarters · filed 2026-08-14 | $182.50K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $77.10K 10-Q · filed 2025-11-10 | $117.28K derived: sum of 2 quarters · filed 2026-08-14 | $147.28K 10-Q · filed 2025-11-10 | $147.28K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $40.18K 10-Q · filed 2026-08-14 | $70.18K 10-Q · filed 2026-08-14 | $70.18K derived: sum of 3 quarters · filed 2026-08-14 | $113.99K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-15 | $30.00K derived: sum of 2 quarters · filed 2026-05-15 | $73.81K derived: sum of 3 quarters · filed 2026-05-15 | $176.91K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $43.81K derived: sum of 2 quarters · filed 2026-04-15 | $146.91K derived: sum of 3 quarters · filed 2026-04-15 | $312.27K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $43.81K 10-Q · filed 2025-11-10 | $43.00K 10-Q · filed 2024-11-19 | $146.91K derived: sum of 2 quarters · filed 2025-11-10 | $312.27K 10-Q · filed 2025-11-10 | $312.00K 10-Q · filed 2024-11-19 | $287.70K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $103.10K 10-Q · filed 2025-08-19 | $104.00K 10-Q · filed 2024-08-19 | $268.46K 10-Q · filed 2025-08-19 | $269.00K 10-Q · filed 2024-08-19 | $243.89K derived: sum of 3 quarters · filed 2025-08-19 | $526.89K derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $165.36K 10-Q/A · filed 2025-08-19 | $165.00K 10-Q · filed 2024-06-28 | $140.79K derived: sum of 2 quarters · filed 2025-08-19 | $423.79K derived: sum of 3 quarters · filed 2025-08-19 | $756.79K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | -$24.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $258.43K derived: sum of 2 quarters · filed 2025-04-15 | $591.43K derived: sum of 3 quarters · filed 2025-04-15 | $900.43K 10-K · filed 2025-04-15 | $901.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $283.00K 10-Q · filed 2024-11-19 | $616.00K derived: sum of 2 quarters · filed 2024-11-19 | $925.00K 10-Q · filed 2024-11-19 | $1.81M derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | $333.00K 10-Q · filed 2024-08-19 | $642.00K 10-Q · filed 2024-08-19 | $1.53M derived: sum of 3 quarters · filed 2024-08-19 | $2.09M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $309.00K 10-Q · filed 2024-06-28 | $1.20M derived: sum of 2 quarters · filed 2024-06-28 | $1.75M derived: sum of 3 quarters · filed 2024-06-28 | $2.75M derived: sum of 4 quarters · filed 2024-06-28 | ||||
| 2022-12-31 | $887.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $1.45M derived: sum of 2 quarters · filed 2024-06-06 | $2.45M derived: sum of 3 quarters · filed 2024-06-06 | $3.05M 10-K · filed 2024-06-06 | ||||
| 2022-09-30 | $558.00K 10-Q/A · filed 2024-06-04 | $1.56M derived: sum of 2 quarters · filed 2024-06-04 | $2.16M 10-Q/A · filed 2024-06-04 | $2.72M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-10 | $1.60M 10-Q · filed 2023-08-10 | $2.16M derived: sum of 3 quarters · filed 2023-08-10 | $3.83M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $601.00K 10-Q · filed 2023-05-11 | $1.16M derived: sum of 2 quarters · filed 2023-05-11 | $2.82M derived: sum of 3 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.22M derived: sum of 2 quarters · filed 2023-03-31 | $4.88M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $1.67M 10-Q · filed 2022-11-21 | $4.32M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |